{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:25:01Z","timestamp":1783099501742,"version":"3.54.6"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K27597"],"award-info":[{"award-number":["23K27597"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K19034"],"award-info":[{"award-number":["24K19034"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bbrc.2026.154042","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T06:50:06Z","timestamp":1779864606000},"page":"154042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dantrolene attenuates steatohepatitis and liver fibrosis by suppressing Ca2+ dysregulation"],"prefix":"10.1016","volume":"827","author":[{"given":"Juri","family":"Sakamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9334-5478","authenticated-orcid":false,"given":"Takeshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minami","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayano","family":"Sasakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoomi","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Inamitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Takami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoaki","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bbrc.2026.154042_bib1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","article-title":"Liver fibrosis \u2014 from bench to bedside","volume":"5","author":"Friedman","year":"2008","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"Suppl","key":"10.1016\/j.bbrc.2026.154042_bib2","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154042_bib3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.tem.2019.02.005","article-title":"Calcium signaling as a therapeutic target for liver steatosis","volume":"30","author":"Ali","year":"2019","journal-title":"Trends Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154042_bib4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3390\/ijms23010256","article-title":"Emerging roles of calcium signaling in the development of non-alcoholic fatty liver disease","volume":"23","author":"Chen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154042_bib5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/j.2040-4603.2013.tb00492.x","article-title":"Calcium signaling in the liver","volume":"3","author":"Amaya","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.bbrc.2026.154042_bib6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fmed.2018.00192","article-title":"Calcium signaling in liver injury and regeneration","volume":"5","author":"Oliva-Vilarnau","year":"2018","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154042_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00441-011-1246-y","article-title":"TGF-\u03b2 in progression of liver disease","volume":"347","author":"Dooley","year":"2012","journal-title":"Cell Tissue Res."},{"issue":"11","key":"10.1016\/j.bbrc.2026.154042_bib8","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003996","article-title":"Ryanodine receptors: structure, expression, molecular details, and function in calcium release","volume":"2","author":"Lanner","year":"2010","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154042_bib9","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1152\/physrev.00013.2002","article-title":"Ryanodine receptor calcium release channels","volume":"82","author":"Fill","year":"2002","journal-title":"Physiol. Rev."},{"issue":"Pt 3","key":"10.1016\/j.bbrc.2026.154042_bib10","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1042\/BJ20041336","article-title":"Probing a putative dantrolene-binding site on the cardiac ryanodine receptor","volume":"387","author":"Paul-Pletzer","year":"2005","journal-title":"Biochem. J."},{"issue":"38","key":"10.1016\/j.bbrc.2026.154042_bib11","doi-asserted-by":"crossref","first-page":"34918","DOI":"10.1074\/jbc.M205487200","article-title":"Identification of a dantrolene-binding sequence on the skeletal muscle ryanodine receptor","volume":"277","author":"Paul-Pletzer","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154042_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13023-015-0310-1","article-title":"Malignant hyperthermia: a review","volume":"10","author":"Rosenberg","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154042_bib13","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1038\/s41598-021-86822-x","article-title":"Enhancing calmodulin binding to ryanodine receptor is crucial to limit neuronal cell loss in alzheimer disease","volume":"11","author":"Nakamura","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.154042_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbrc.2022.07.111","article-title":"Dantrolene, a stabilizer of the ryanodine receptor, prevents collagen-induced arthritis","volume":"624","author":"Nawata","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.154042_bib15","article-title":"Dantrolene prevents hepatic steatosis by reducing cytoplasmic Ca2+ level and ER stress","volume":"23","author":"Tamitani","year":"2020","journal-title":"Biochem. Biophys. Rep."},{"issue":"6","key":"10.1016\/j.bbrc.2026.154042_bib16","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1210\/en.2010-1036","article-title":"Constitutive role for IRE1\u03b1-XBP1 signaling pathway in the insulin-mediated hepatic lipogenic program","volume":"152","author":"Ning","year":"2011","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.bbrc.2026.154042_bib17","article-title":"Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease","volume":"7","author":"Schwabe","year":"2025","journal-title":"JHEP Rep."},{"issue":"11","key":"10.1016\/j.bbrc.2026.154042_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108213","article-title":"A rat liver cell atlas reveals intrahepatic myeloid heterogeneity","volume":"26","author":"Pouyabahar","year":"2023","journal-title":"iScience"},{"issue":"45","key":"10.1016\/j.bbrc.2026.154042_bib19","doi-asserted-by":"crossref","first-page":"34086","DOI":"10.1074\/jbc.M607788200","article-title":"Ryanodine receptors in liver","volume":"281","author":"Pierobon","year":"2006","journal-title":"J. Biol. Chem."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26008065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26008065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:07:00Z","timestamp":1783098420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26008065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":19,"alternative-id":["S0006291X26008065"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154042","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dantrolene attenuates steatohepatitis and liver fibrosis by suppressing Ca2+ dysregulation","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"154042"}}